Andrea E Formella Selected Research

Parkinson Disease (Parkinson's Disease)

3/2024	Extended-release amantadine for OFF-related dystonia in Parkinson's disease.
3/2022	Amantadine delayed release/extended release capsules significantly reduce OFF time in Parkinson's disease.
1/2022	Potential utility of amantadine DR/ER in persons with Parkinson's disease meeting 5-2-1 criteria for device aided therapy.
12/2021	Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson's Disease and Dyskinesia.
1/2021	Amantadine ER (Gocovri®) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea E Formella Research Topics

Disease

5	Parkinson Disease (Parkinson's Disease) 03/2024 - 01/2021
5	Dyskinesias (Dyskinesia) 03/2022 - 01/2021
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2018 - 11/2014
4	Multiple Sclerosis 10/2018 - 11/2014
3	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2018 - 06/2016
3	Stroke (Strokes) 06/2018 - 06/2016
2	Dementia (Dementias) 09/2016 - 06/2016
1	Dystonia (Limb Dystonia) 03/2024
1	Edema (Dropsy) 01/2022

Drug/Important Bio-Agent (IBA)

6	Amantadine (Aman)FDA LinkGeneric 03/2024 - 01/2021
5	Dextromethorphan (Racemethorphan)FDA LinkGeneric 10/2018 - 11/2014
5	Quinidine (Chinidin)FDA LinkGeneric 10/2018 - 11/2014
4	Levodopa (L Dopa)FDA LinkGeneric 03/2022 - 01/2021
1	Capsules (Microcapsules)IBA 12/2021

Therapy/Procedure

2	Therapeutics 01/2022 - 12/2021
1	Ambulatory Care (Outpatient Care) 01/2022